Wellgistics Health Joins OptiSource to Expand Access and Drive Savings for Independent Pharmacies
TAMPA, FL / ACCESS Newswire / June 10, 2025 / Wellgistics Health (NASDAQ:WGRX) ("Wellgistics Health"), a next-generation drug distribution, digital script routing, and hub fulfillment platform, is proud to announce its official membership in OptiSource, LLC, a group purchasing organization that provides innovative business solutions, group purchasing programs, and other efficiency-enhancing and cost-saving services to its members. This strategic move significantly enhances Wellgistics Health's purchasing power, product access, and support for community-based pharmacy partners.
By joining OptiSource, Wellgistics Health strengthens its ability to offer competitive pricing on generics, greater formulary depth, and expanded access to shortage and specialty items, ensuring that independent pharmacies can continue to thrive in a landscape dominated by larger chain and vertically integrated competitors.
"Our partnership with OptiSource reinforces our commitment to empowering independent pharmacies with every advantage possible," said Brian Norton, CEO of Wellgistics Health. "Through OptiSource, we're bringing our customers more purchasing power, more products, and more confidence in their supply chain."
About OptiSource
OptiSource is a national generic sourcing consortium composed of over a dozen regional pharmaceutical wholesalers and distributors. It works directly with top-tier manufacturers to negotiate volume-based pricing, ensuring smaller players receive the kinds of terms typically reserved for the industry's largest buyers.
As a member of OptiSource, Wellgistics Health gains access to:
Nationally negotiated pricing across a wide range of generics, including specialty and niche productsImproved contract terms and rebate programsStability of long-standing contracts and industry reputationStrategic partnerships with the largest generic manufacturers
Empowering Independent Pharmacies
Wellgistics Health has long been an advocate for independent pharmacies, offering customized solutions, transparent pricing, and hands-on service. With this new affiliation, the Company strengthens its role as a preferred secondary and primary source of generic pharmaceuticals for retail, compounding, and specialty providers across the U.S.
About Wellgistics Health
Wellgistics Health (NASDAQ: WGRX) moves medications from maker to taker-faster, cheaper, and smarter. Its vertically integrated platform connects U.S.-based pharmaceutical manufacturers directly to providers, pharmacies, employer groups, and patients. From wholesale distribution and digital routing to cash-pay fulfillment and hub services like eligibility, adherence, and prior authorization-it manages the entire prescription journey. A PBM alternative, but PBM-agnostic, Wellgistics Health delivers seamless, compliant, end-to-end solutions designed to restore access, transparency, and trust across the healthcare system.
For more information, visit www.wellgisticshealth.com.
Forward-Looking Statements
This press release may contain forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When Wellgistics Health uses words such as "may, "will, "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. These forward-looking statements include, without limitation, Wellgistics Health's statements regarding Wellgistics Health's strategy and descriptions of its future operations, prospects, and plans, including without limitation its plan in connection with certain financings and cryptocurrencies and outlook and actions with respect to incurring future expenses. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from Wellgistics Health's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and other risks detailed in our reports and statements filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in Wellgistics Health's filings with the SEC, which are available for review at www.sec.gov.
For more information, please contact:
Media Contact: media@wellgisticshealth.comInvestor Relations: investors@wellgisticshealth.com
Investor Relations Contact:Skyline Corporate Communications Group, LLCScott Powell, President1177 Avenue of the Americas, 5th FloorNew York, NY 10036Office: (646) 893-5835Email: info@skylineccg.com
SOURCE: Wellgistics Health, Inc.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
CoreWeave reportedly a key player in Google-OpenAI partnership
-- CoreWeave is set to provide computing capacity to Google (NASDAQ:GOOGL) Cloud as part of Google's newly formed partnership with OpenAI, according to a Reuters report on Wednesday. The arrangement involves CoreWeave supplying cloud computing services built on Nvidia (NASDAQ:NVDA)'s graphics processing units to Google's cloud unit. Google will then sell this computing capacity to OpenAI to help meet the growing demand for services such as ChatGPT. In addition to CoreWeave's resources, Google will also provide some of its own computing resources to OpenAI. The deal demonstrates how the high demand for AI computing resources is creating new business alliances, even among the industry's fiercest rivals. Related articles CoreWeave reportedly a key player in Google-OpenAI partnership Dana stock surges amid $2.7 billion Off-Highway business sale to Allison Oklo and Centrus Energy stocks jump after DoD nuclear reactor award Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
37 minutes ago
- Yahoo
Dave & Buster's (PLAY) Stock Trades Up, Here Is Why
Shares of arcade company Dave & Buster's (NASDAQ:PLAY) jumped 14.8% in the afternoon session after the company reported first-quarter 2025 results and provided encouraging updates on sales trends, as revenue came in line with expectations. The company noted improved momentum following the reintroduction of the Eat & Play combo, adjustments to menu pricing, and changes to the incentive structure for store managers. Additionally, free cash flow turned positive, which is a significant boost as management attempts to turn around the business. Given that markets are forward-looking, the stock's reaction suggests investors were able to look past the bottom line weakness during the quarter as operating profits and earnings fell short of Wall Street's estimates. The shares closed the day at $30.46, up 17.7% from previous close. Is now the time to buy Dave & Buster's? Access our full analysis report here, it's free. Dave & Buster's shares are extremely volatile and have had 42 moves greater than 5% over the last year. But moves this big are rare even for Dave & Buster's and indicate this news significantly impacted the market's perception of the business. The previous big move we wrote about was 15 days ago when the stock gained 5.5% on the news that the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. Companies with substantial business ties to Europe likely had some relief as the delay reduced near-term cost pressures and preserved cross-border demand. Dave & Buster's is down 0.3% since the beginning of the year, and at $30.20 per share, it is trading 40% below its 52-week high of $50.35 from June 2024. Investors who bought $1,000 worth of Dave & Buster's shares 5 years ago would now be looking at an investment worth $2,064. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
40 minutes ago
- CNBC
Stock futures are little changed after S&P 500 ends three-day win streak: Live updates
Traders wait for Voyager Technologies to begin trading during the company's IPO at the New York Stock Exchange (NYSE) in New York City, U.S., June 11, 2025. Brendan McDermid | Reuters Stock futures were relatively unchanged on Wednesday after the S&P 500 saw its first negative session in four. S&P 500 futures traded down by 0.1%, along with Nasdaq 100 futures . Futures tied to the Dow Jones Industrial Average dropped 44 points, or 0.1%. In extended trading, shares of Oracle surged more than 7% after its fiscal fourth-quarter results beat on the top and bottom lines. The company also indicated more cloud growth ahead, saying in a statement that cloud infrastructure revenue will rise by more than 70% in fiscal 2026, up from a 50% growth rate in the prior fiscal year. Wednesday marked a losing session on Wall Street, with the S&P 500 snapping its three-day win streak, as did the Nasdaq Composite . But the moves were slight. The broad market index fell about 0.3%, while tech-heavy Nasdaq dropped 0.5%. The Dow Jones Industrial Average was flat. While the day's losses put the S&P 500 a bit further away from reaching a new record high, the index is also still just more than 2% below its late February record. Those moves come after consumer prices rose less than expected in May, as the consumer price index increased 0.1% for the month. That's less than the Dow Jones forecast for 0.2%. Core CPI, which excludes food and energy prices, also increased less than expected. "I don't think the market has a lot of faith that we're not going to see at least a little bit higher inflation," Scott Wren, senior global market strategist at Wells Fargo, told CNBC's "Closing Bell" Wednesday. "With all the things going on, the economy slowing, earnings growth likely to slow, lots of trade negotiations to still work through, is there really a good reason to take a run at the record high? I don't know about that. It makes a lot of sense to me that we'd be choppy and maybe see a little downside here." Investors are now looking ahead to May's reading of the producer price index, due out at 8:30 a.m. ET on Thursday. Economists polled by Dow Jones are expecting the index to show a gain of 0.2% for the period. Subtracting out food and energy, core PPI is expected to show growth of 0.3% on the month. The Street is also waiting for more developments on trade, especially between the U.S. and China, as talks between the two countries have been a focal point this week. While officials reached an agreement in London, the deal still awaits approval from U.S. President Donald Trump and Chinese President Xi Jinping. Trump said in a post on Truth Social earlier Wednesday that "WE ARE GETTING A TOTAL OF 55% TARIFFS, CHINA IS GETTING 10%." However, Commerce Secretary Howard Lutnick later said that U.S. levies on goods from China won't change from their current levels. Rising tensions between the U.S. and Iran will also be in focus. U.S. crude oil futures jumped more than 4% on Wednesday after Trump expressed doubt that the two countries could reach a nuclear deal.
